NextPlat (NXPL)
Sells satellite connectivity products online while operating pharmacy and healthcare-data services.
Something off on this page? Send us feedback.
Earns from online sales of satellite connectivity products and services and from PharmcoRx pharmacy, 340B and ClearMetrX data services, combining operationally distinct e-commerce and healthcare businesses within one public company.
Separately reports e-commerce and healthcare operations. Global Telesat Communications, Orbital Satcom and Outfitter Satellite sell satellite-enabled voice and data devices, trackers, and M2M/IoT connectivity, earning from hardware and related airtime services through owned websites and third-party marketplaces worldwide.
Runs PharmcoRx pharmacies for retail and long-term-care prescription fulfillment, medication management, delivery, and 340B contract-pharmacy work. ClearMetrX adds pharmacy-data analytics, third-party administration and medication-adherence reporting for healthcare customers.
Marketplace access, satellite-network suppliers and airtime relationships shape the e-commerce operation. Pharmacy revenue relies on prescription dispensing and payer reimbursement, 340B and other contract services, while both pharmacy and data workflows operate under pharmacy, reimbursement, 340B and health-data requirements.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $11.9M · Total debt $1.6M · Total assets $28.7M · Shareholders' equity $16.4M
- Revenue
- $11.9M
- Operating income
- −$127.0K
- Net income
- −$144.0K
No dividends on record.
| Institutions13 holders · as of Mar 31, 2026 | 2.04% | 55.3K shares | |
| Insiders15 holders · as of Jul 2, 2026 | 56.39% | 1.53M shares | |
| Otherremainder | 41.57% | 1.13M shares |
2.71M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Rodney BarretoInsiderdirector | 24.08% | 653,315 | Form 4filed Jul 2, 2026 ↗ |
Charles M. FernandezInsiderdirector, 10 percent owner, officer: Chairman & CEO | 16.83% | 456,685 | Form 4filed Oct 4, 2024 ↗ |
Douglas EllenoffInsiderdirector | 7.09% | 192,386 | Form 4filed Jul 2, 2026 ↗ |
Anthony ArmasInsiderdirector | 4.21% | 114,259 | Form 4filed Jul 2, 2026 ↗ |
David PhippsInsiderdirector, officer: Chief Executive Officer | 2.66% | 72,179 | Form 4filed Dec 9, 2025 ↗ |
| See all 25 → | |||
Form 4 — an insider's transaction report
Insider tradesForm 4
No open-market trades in the last 12 months.
- CVS Health
Retail pharmacy and PBM scale in prescription and contract services.
- Cigna
PBM, specialty pharmacy and home delivery at national scale.
- UnitedHealth Group
Optum Rx combines pharmacy benefits, specialty care and digital services.
- Globalstar
SPOT tracking hardware and subscriptions target remote users directly.
- Garmin
inReach combines satellite communicators, tracking and paid service plans.
- Humana
CenterWell offers integrated mail-order, specialty and retail pharmacy.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| NextPlat | $9.22 | −4.36% | $25.1M | — | — | 0.5 | −10.3% |
| CVS Health | $96.93 | −0.31% | $124.06B | 25.7 | 12.0 | 0.3 | +7.3% |
| Cigna | $284.76 | +0.68% | $74.74B | 11.7 | 8.9 | 0.3 | +6.6% |
| UnitedHealth Group | $399.46 | −0.06% | $362.95B | 25.7 | 18.7 | 0.8 | +0.4% |
| Globalstar | $81.46 | +0.11% | $10.49B | — | — | 37.4 | −3.5% |
| Garmin | $279.75 | +1.36% | $53.24B | 28.5 | 26.9 | 6.9 | +11.4% |
| Humana | $400.97 | −0.04% | $48.17B | 38.0 | 32.6 | 0.3 | +26.2% |
| Median | 25.7 | 18.7 | 0.6 | +6.9% |